Jun 17, 2020 / 05:00PM GMT
Operator
Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Ovid Therapeutics webinar. (Operator Instructions)
It is now my pleasure to turn the call over to Dr. Jeremy Levin, Chairman and CEO of Ovid Therapeutics. Please go ahead.
Jeremy Max Levin - Ovid Therapeutics Inc. - Chairman & CEO
Thank you, Jonathan. Hello, everyone. Thank you for joining us today. As we promised, we would provide an information day on 935. And before I start into that, this is in fact -- I'd like you please to take note of the forward-looking statements. And obviously, as a public company, these are important.
Today's talk will be given by a number of different people. I would like to just say we made a promise to the investment committee that we would educate you as much as possible about 935. And to do that today, we've lined up the best possible array of people that we could in this short period of time so that for a short period of time, you'll have the chance to ask questions of them and get a much deeper appreciation of what we're
Ovid Therapeutics Inc. - Special Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot